Christie & Co is the UK’s leading specialist pharmacy agent with a team of special business agents offering advice on a national, regional and local basis. In 2016 we sold 70 pharmacies with a combined value in excess of £68 million.

Click here if you're searching for a pharmacy for sale.

So what do we offer?

Purchasing a pharmacy?

Why not register on the website now for details of what we have for sale? It costs nothing and we'll email you new instructions when we take them, free of charge and automatically. 

Alternatively please don’t hesitate to contact one of the pharmacy team to talk through your requirements and to obtain an understanding of market dynamics in your area.

We can also advise on all aspects of the purchasing process and help you raise funding through our sister company Christie Finance

Selling a pharmacy in the next 5 years?

It is important to seek professional advice at an early stage. Our local specialist Business Agent will visit you at a convenient time and talk you through the sale process so that you can make an informed decision when the time is right. They will also liaise with your other advisers to ensure advice is tailored to your own personal circumstances.  

Initial marketing advice is provided free of charge, without obligation and on a strictly confidential basis. Our agents will meet with you at a convenient time either inside or outside business hours so complete discretion is assured.

For an honest view of the market and expert advice on how to achieve the best price for your business, get in touch with one of our pharmacy specialists or call our Head of Pharmacy, Tony Evans, for an initial discussion on the above number.  

Formal valuations and a range of other services

Our team of Chartered Surveyors across our 16 office network offers a range of valuation and property related services to the pharmacy sector. These include:

  • Accredited 'Red Book' valuations for loan security purposes
  • Valuations for partnership set up and incorporation
  • Dispute resolution/expert witness assignments
  • Rent reviews for landlord or tenant
  • Freehold 'bricks and mortar' valuations
  • Asset reviews for estate portfolios
  • Consultancy services to support relocation
  • Rating Advice 

Our team of valuers work with a wide range of clients from independent operators through to the largest corporate clients. With access to up-to-date transactional evidence, they understand the nuances of the market and factors affecting it.

For initial advice to discuss the services we provide please contact either Christopher Vowles or Tony Evans.


Movement in average prices year on year

  View all pharmacies for sale

Pharmacies for sale

Market view – 2017 set to be another busy year

Pharmacy Market Update – Q1 2017

Despite the proposed funding cuts to the sector announced by the DoH in December 2015, the market saw no let up in demand or activity throughout the course of 2016. Completing 70 sales with a combined value in excess of £68.75 million we also agreed on 78 pharmacies sales. Applicant demand continued at a pace with an 8.9% increase in numbers leading an all-time high of just over 5,000 applicants registered with us. Appetite is fuelled by buyers of all types, from first-time buyers (as newly qualified and locum pharmacists sought to mitigate the effects of diminishing locum rates and inconsistency of income), to existing independent pharmacy owners and multiple operators, seeking to expand their businesses.
Where pharmacies are placed on to the market, significant interest is more often than not generated, leading to competitive bidding. As a result, our Business Outlook Average Price Index and analysis of transactions we completed over the year pointed to average pharmacy prices increasing by 12% in 2017.
Purchaser appetite is experienced across all price ranges and areas with 'hot spots' in London and other major conurbations across the UK.
In October 2016 the DoH announced that funding cuts would be imposed from the beginning of December 2016. The cuts would be implemented in two stages, with a reduction of £113 million to the global funding settlement in 2016/17, followed by a further £95 million in 2017/18 to £2.592 billion. The announcement has been met with significant opposition culminating in two applications for Judicial Reviews, firstly by the PSNC and secondly by the NPA. The reviews are set to be heard in the High Court in March 2017.
Despite this sales activity and applicant demand remains robust with sales being agreed in line with pre-announcement metrics.  On average we continue to generate seven offers per pharmacy sold and delivering an over-performance against quoted guide prices of between 110% and 120%.
2017 has started off with brisk activity. We expect this to continue along with an uplift in sales instructions as the funding cuts start to be felt by contractors from March this year.